In the clinic, rhTNFR:Fc is used to neutralize TNF-α to alleviate the aberrant proinflammatory response during the pathogenesis of rheumatoid arthritis, ankylosing spondylitis, psoriasis, and Crohn’s disease [28–30]. The gene discussed is TNF; the disease is Crohn disease.